undefined undefined
NaN.000
NaN.00%
Orphan drugs -- medicines to treat rare diseases -- from Johnson & Johnson (NYSE:JNJ), Roche (OTCQX:RHHBY), and AstraZeneca (NASDAQ:AZN) will allow these companies to reign as the top 3 orphan drugmak...
今天 01:00
THOUSAND OAKS, Calif., April 26, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Age...
04-26 21:00
SPROUT 52-Week Data Demonstrate Durable Response and Consistent Safety Profile of Oral Otezla in Children with Moderate to Severe Plaque Psoriasis Late-Breaking Phase 3 Study of Otezla in Pa...
03-10 01:20
THOUSAND OAKS, Calif., March 6, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.25 per share dividend for the second quarter of 2024. The d...
03-07 05:00
TNX-1500, a third generation anti-CD40L mAb, was Fc-modified to preserve the activity and bioavailability of first generation mAbs while addressing their thrombosis risk Sanofi projects its Fc-modified humanized
03-05 21:07
THOUSAND OAKS, Calif., Feb. 26, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the opening of its manufacturing site in Central Ohio, the newest in its global operations network an...
02-26 22:00
根据美国证券交易委员会(SEC)披露,摩根士丹利递交了截止至2023年12月31日的第四季度持仓报告(13F)。 据统计,摩根士丹利第四季度持仓总市值为1.1...
02-16 20:59
Amgen's Q4 2023: 15% net profit growth, $8.2 billion total revenues beat expectations. Prolia leads with 12% sales jump. Analysts' reactions and price targets.
02-08 03:36
转自:金融界 本文源自:猎云精选 进入2024年不久,高瓴资本就收获了一个IPO。 本周五,生物科技公司ArriVent Biopharma(以下简称“Ar...
01-26 21:30